BioSpace News Archive

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced, as required by Nasdaq Stock Market rules, the grant of inducement awards to new employees.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Vabysmo™ (faricimab-svoa) for the treatment of wet, or neovascular, age-related macular degeneration (AMD) and diabetic macular edema (DME).

A rare lung disease often terminal, idiopathic pulmonary fibrosis is an interstitial lung disease affecting the lung interstitium.

Impetigo also known as impetigo contagiosa or pyoderma, is a bacterial skin infection highly contagious in nature.

Molecular imaging is a breakthrough technology that was introduced to the medical diagnostics world in the early 21st century.

Neuralgia refers to an abnormal symptom that comes with several effects, such as severe, burning, and sharp pain owing to the presence of a damaged or an irritated nerve.

Calliditas Therapeutics AB announced the commercial availability and initial sales of TARPEYO™, the first and only FDA approved treatment for IgA nephropathy, indicated for reduction of proteinuria in adults with primary IgA nephropathy at risk of rapid disease progression, generally considered a urine protein-to-creatinine ratio ≥1.5g/g.

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it has received a Notice of Allowance from the Canadian Patent Office for patent application No. 3101853 entitled: Compositions and Methods for Treating Idiopathic Pulmonary Fibrosis.

Nutriband Inc. announced the receipt of an Issue Notification from the United States Patent and Trademark Office for its United States patent entitled, “Abuse and Misuse Deterrent Transdermal System,” that protects its AVERSA™ transdermal abuse deterrent technology.

The registration recognizes I Peace’s cell manufacturing facility as suitable for drug manufacturing, based on detailed information submitted to the FDA.